Author details

Full Name

John Z Sanborn

Affiliation

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37505926	A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa.	Cancer Epidemiol Biomarkers Prev	2023
33418062	Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy<sup>â¿¿</sup>.	Ann Oncol	2021
34172517	Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy.	J Immunother Cancer	2021
32736587	A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.	Breast Cancer Res	2020
31967692	Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.	Oncologist	2020
31911616	Multiregion exome sequencing of ovarian immature teratomas reveals 2N near-diploid genomes, paucity of somatic mutations, and extensive allelic imbalances shared across mature, immature, and disseminated components.	Mod Pathol	2020
32493840	Transcriptomic silencing as a potential mechanism of treatment resistance.	JCI Insight	2020
33077815	Large scale, robust, and accurate whole transcriptome profiling from clinical formalin-fixed paraffin-embedded samples.	Sci Rep	2020
31292145	Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy.	Cancer Immunology Research	2019
29642018	A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.	Cell Rep	2018
29765141	Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study.	Mod Pathol	2018
29721196	Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer.	Oncotarget	2018
29760388	Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma.	Nat Commun	2018
26677003	Multiple Hereditary Infundibulocystic Basal Cell Carcinoma Syndrome Associated With a Germline SUFU Mutation.	JAMA Dermatol	2016
26061751	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	N Engl J Med	2015
25732040	Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome.	Ann Oncol	2015
25962591	Erratum to: Modeling precision treatment of breast cancer.	Genome Biol	2015
26343386	Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.	Nat Genet	2015
26286987	Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.	Proc Natl Acad Sci U S A	2015
25456125	Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes.	Cell Rep	2014
24176112	Modeling precision treatment of breast cancer.	Genome Biol	2013
24120142	The somatic genomic landscape of glioblastoma.	Cell	2013
23940299	Double minute chromosomes in glioblastoma multiforme are revealed by precise reconstruction of oncogenic amplicons.	Cancer Res	2013
23748957	The UCSC Interaction Browser: multidimensional data views in pathway context.	Nucleic Acids Res	2013
22006338	Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.	Proc Natl Acad Sci U S A	2011
21059681	The UCSC Cancer Genomics Browser: update 2011.	Nucleic Acids Res	2011
20529912	Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.	Bioinformatics	2010
19333237	The UCSC Cancer Genomics Browser.	Nat Methods	2009
18085818	Comparative genomics search for losses of long-established genes on the human lineage.	PLoS Comput Biol	2007